Zantac Lawsuit
NDMA Contamination and Cancer Risk
Zantac (ranitidine) contained the carcinogen NDMA and has been linked to various cancers. If you developed cancer after using Zantac, you may have a legal claim.
What Is Zantac?
Zantac (ranitidine) is a common over-the-counter and prescription medication used to treat heartburn, GERD, and ulcers. It was widely used by millions of patients worldwide.
Manufactured by GlaxoSmithKline, Zantac was voluntarily withdrawn from the market in 2020 due to contamination concerns.
NDMA Contamination
The FDA discovered that Zantac and ranitidine products contained unacceptable levels of N-nitrosodimethylamine (NDMA), a probable human carcinogen.
NDMA can cause cancer and other serious health conditions. The contamination may have been present in the drug for years before detection.
Cancer Risk
Lawsuits allege that Zantac use significantly increased the risk of various cancers, including stomach cancer, bladder cancer, and colorectal cancer.
Long-term users are at highest risk, with cumulative exposure playing a critical role in cancer development.
Who May Qualify
Individuals who used Zantac or ranitidine products for extended periods and subsequently developed cancer may qualify for a claim.
Documentation of Zantac use, diagnosis dates, and medical records showing the cancer development are essential for pursuing a case.
Legal Status
Thousands of Zantac lawsuits have been filed, and many are consolidated in MDL proceedings. Settlement discussions are ongoing, and jury trials have begun in several jurisdictions.
Contact us to discuss your potential claim against GlaxoSmithKline.
Free Case Review
Evaluate your Zantac cancer claim.
Start Your ReviewNo fees. No commitments. Confidential.
Key Facts
- Used for heartburn and GERD treatment
- Contained NDMA contamination
- Voluntarily withdrawn in 2020
- Linked to stomach, bladder, and colorectal cancer
The information on this page is for general informational purposes only and does not constitute legal advice.